Inflammatory breast cancer: a race against screening

Inflammatory breast cancer [IBC] is a rare and aggressive form of breast cancer that is characterized by rapid progression, younger age of onset, and poor prognosis. These findings underline a long list of differential diagnosis where clinical, radiological and histological inputs are essential. One limitation to establishing the diagnosis is a poor sensitivity of a test with high negative predictive value. In this paper, we report the case of a rapid growing IBC where two imaging techniques failed at establishing the diagnosis

two-front war: targeting synchronous metastatic pancreatic and renal cell carcinomas with the combination of gemcitabine and sunitinib

The occurrence of multiple synchronous primary tumors is extremely rare. The management plan of synchronous cancers has long been debatable and difficult mainly in tumors with different molecular characteristics. In this report, we present the second case in literature of a concomitant diagnosis of a metastatic pancreatic adenocarcinoma and a locally advanced renal cell carcinoma. We also elaborate on our management combining chemo-therapy and targeted therapy through an extensive review of literature